Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Baxter

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Biophysical Journal|June 28, 2005
Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptorsLeandro Martínez, Milton T Sonoda, Paul Webb, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2009
Identification of CCR4 and other essential thyroid hormone receptor co-activators by modified yeast synthetic genetic array analysisManjapra Govindan, Xianwang Meng, Clyde L Denis, et al.
HIV Clinical Trials|September 30, 2005
Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapyRodger D MacArthur, George Perez, Sharon Walmsley, et al.
Current HIV Research|April 1, 2010
Susceptibility of HIV-1 to tipranavir and other antiretroviral agents in treatment-experienced patients: The UTILIZE StudyJohn D Baxter, Laveeza Bhatti, Eoin Coakley, et al.
Molecular Endocrinology (Baltimore, Md.)|December 31, 2011
Research resource: The estrogen receptor α cistrome defined by DamIPRui Xiao, Deqiang Sun, Stephen Ayers, et al.
Molecular and Cellular Endocrinology|October 22, 2008
Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell linesVanya Shah, Phuong Nguyen, Ngoc-Ha Nguyen, et al.
Pharmacological Reviews|November 30, 2006
International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptorsFrédéric Flamant, John D Baxter, Douglas Forrest, et al.
Journal of Medicinal Chemistry|July 12, 2002
Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitmentNgoc-Ha Nguyen, James W Apriletti, Suzana T Cunha Lima, et al.
Antiviral Therapy|July 22, 2006
Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patientsMichael J Kozal, Katherine Huppler Hullsiek, Robert Leduc, et al.
Nuclear Receptor Signaling|November 8, 2006
Corepressor/coactivator paradox: potential constitutive coactivation by corepressor splice variantsXianwang Meng, Vishnuka D Arulsundaram, Ahmed F Yousef, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Biophysical Journal|June 28, 2005
Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptorsLeandro Martínez, Milton T Sonoda, Paul Webb, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2009
Identification of CCR4 and other essential thyroid hormone receptor co-activators by modified yeast synthetic genetic array analysisManjapra Govindan, Xianwang Meng, Clyde L Denis, et al.
HIV Clinical Trials|September 30, 2005
Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapyRodger D MacArthur, George Perez, Sharon Walmsley, et al.
Current HIV Research|April 1, 2010
Susceptibility of HIV-1 to tipranavir and other antiretroviral agents in treatment-experienced patients: The UTILIZE StudyJohn D Baxter, Laveeza Bhatti, Eoin Coakley, et al.
Molecular Endocrinology (Baltimore, Md.)|December 31, 2011
Research resource: The estrogen receptor α cistrome defined by DamIPRui Xiao, Deqiang Sun, Stephen Ayers, et al.
Molecular and Cellular Endocrinology|October 22, 2008
Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell linesVanya Shah, Phuong Nguyen, Ngoc-Ha Nguyen, et al.
Pharmacological Reviews|November 30, 2006
International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptorsFrédéric Flamant, John D Baxter, Douglas Forrest, et al.
Journal of Medicinal Chemistry|July 12, 2002
Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitmentNgoc-Ha Nguyen, James W Apriletti, Suzana T Cunha Lima, et al.
Antiviral Therapy|July 22, 2006
Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patientsMichael J Kozal, Katherine Huppler Hullsiek, Robert Leduc, et al.
Nuclear Receptor Signaling|November 8, 2006
Corepressor/coactivator paradox: potential constitutive coactivation by corepressor splice variantsXianwang Meng, Vishnuka D Arulsundaram, Ahmed F Yousef, et al.
Pageof 9